BRIEF published on 09/05/2024 at 09:05, 2 days 18 hours ago Biotest AG ouvre son 13e centre de collecte de plasma en Allemagne Allemagne Biotest AG Collecte De Plasma Traitements Médicaux Défense Des Droits Des Patients
BRIEF published on 09/05/2024 at 09:05, 2 days 18 hours ago Biotest AG Opens 13th Plasma Collection Center in Germany Germany Patient Advocacy Biotest AG Plasma Collection Medical Treatments
PRESS RELEASE published on 09/05/2024 at 09:00, 2 days 18 hours ago Biotest AG opens 13th plasma collection center in Germany Biotest AG opens 13th plasma collection center in Germany to ensure long-term plasma supply. State-of-the-art center in Karlsruhe operated by Plasma Service Europe GmbH, a subsidiary of Biotest AG Donations Germany Biotest AG Plasma Collection Center Plasma Service Europe GmbH
BRIEF published on 08/28/2024 at 09:05, 10 days 18 hours ago Le Dr Jörg Schüttrumpf démissionne du conseil d'administration de Biotest AG Conseil D'administration Biotest AG Développement De Produits Jörg Schüttrumpf Groupe Grifols
BRIEF published on 08/28/2024 at 09:05, 10 days 18 hours ago Dr. Jörg Schüttrumpf Resigns from Biotest AG Management Board Management Board Biotest AG Product Development Jörg Schüttrumpf Grifols Group
PRESS RELEASE published on 08/28/2024 at 09:00, 10 days 18 hours ago Dr. Jörg Schüttrumpf resigns from the Management Board of Biotest AG Dr. Jörg Schüttrumpf resigns as Chief Scientific Officer of Biotest AG to focus on role as Chief Scientific Innovation Officer of Grifols Group, effective August 31, 2024 Resignation Management Board Biotest AG Grifols Group Dr. Jörg Schüttrumpf
BRIEF published on 08/06/2024 at 09:05, 1 month 1 day ago Biotest Sees 35% Sales Spike in First Half of 2024 Financial Results Revenue Growth FDA Approval Biotest Yimmugo®
BRIEF published on 08/06/2024 at 09:05, 1 month 1 day ago Biotest voit ses ventes augmenter de 35 % au premier semestre 2024 Résultats Financiers Hausse Des Revenus Approbation De La FDA Biotest Yimmugo®
PRESS RELEASE published on 08/06/2024 at 09:00, 1 month 1 day ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG reports 35% sales increase to Euro 372 million in H1 2024. EBIT reaches Euro 78.4 million. FDA approves Yimmugo® and BNL facility. Positive revenue and earnings growth Revenue Growth FDA Approval Sales Increase Biotest AG H1 2024
BRIEF published on 07/30/2024 at 08:05, 1 month 8 days ago Biotest Reports 35% Increase in Sales for First Half of 2024 Financial Results Revenue Increase FDA Approval Sales Growth Biotest AG
Published on 09/07/2024 at 01:30, 1 day 1 hour ago Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
Published on 09/07/2024 at 00:30, 1 day 2 hours ago Cheech and Chong’s Global Holding Company Responds to California’s Proposed Emergency Hemp Ban
Published on 09/06/2024 at 23:15, 1 day 3 hours ago BluSky Carbon Announces Extension of Strategic Marketing Agreement
Published on 09/07/2024 at 14:00, 13 hours 12 minutes ago Litigation costs drive US liability claims by 57% over past decade, reveals Swiss Re Institute
Published on 09/06/2024 at 22:00, 1 day 5 hours ago Successful completion of preset purchase plan for the acquisition of Northern Data Group shares by CEO Aroosh Thillainathan
Published on 09/06/2024 at 18:45, 1 day 8 hours ago Molten Ventures Plc: POS-Transaction in Own Shares
Published on 09/06/2024 at 18:15, 1 day 8 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/06/2024 at 17:56, 1 day 9 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/06/2024 at 18:00, 1 day 9 hours ago Declaration of voting rights at the end of August 2024